Related Experiment Video
Updated: Aug 23, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a
N E MacDonald1, S A Halperin, B J Law
1University of Ottawa, Ontario, Canada. macdonaldvn@cheo.on.ca
Insights
Meningococcal C conjugate vaccine is more effective in toddlers than polysaccharide vaccine, inducing better antibody responses and immunologic memory. This conjugate vaccine overcomes poor responses seen with older vaccines in young children.
Area of Science:
- Immunology
- Vaccinology
- Pediatric Infectious Diseases
Background:
- Meningococcal polysaccharide vaccines elicit poor immune responses in infants and toddlers.
- Invasive meningococcal disease poses a high risk to these age groups.
- Meningococcal C conjugate vaccines present a potential solution to overcome poor immunogenicity.
Purpose of the Study:
- To evaluate the immunogenicity of meningococcal C conjugate vaccine in toddlers.
- To assess the induction of immunologic memory following vaccination in toddlers.
Main Methods:
- A multicenter, randomized, observer-blinded controlled trial involving 211 healthy toddlers (15-23 months).
- Participants received two doses of meningococcal C conjugate vaccine, plain meningococcal polysaccharide vaccine, or hepatitis B virus vaccine, followed by a booster dose 12 months later.
- Outcomes measured included IgG anticapsular antibody concentrations and complement-mediated bactericidal antibody levels.
Main Results:
- Meningococcal C conjugate vaccine induced significantly higher IgG responses compared to polysaccharide vaccine after both doses.
- Elevated antibody titers persisted for at least 12 months in the conjugate vaccine group.
- The conjugate vaccine primed toddlers demonstrated a robust booster response to polysaccharide vaccine, while polysaccharide priming led to hyporesponsiveness.
Conclusions:
- Meningococcal C conjugate vaccine is highly immunogenic in toddlers, inducing significant antibody titers and immunologic memory.
- The conjugate vaccine overcomes the limitations of polysaccharide vaccines in this age group.
- Polysaccharide vaccines are less effective and may induce a hyporesponsive state in toddlers.
Context:
Meningococcal polysaccharide vaccines are not used routinely in infants and toddlers, the groups at highest risk of invasive disease, because of poor immunologic responses to the Neisseria meningitidis serogroup C polysaccharide in these age groups. Meningococcal C conjugate vaccines offer the prospect of circumventing this problem.
Objective:
To assess the immunogenicity and the induction of immunologic memory in toddlers by meningococcal C conjugate vaccine.
Design:
A multicenter, randomized, observer-blinded controlled trial.
Setting:
Urban and suburban family medicine or pediatric practices.
Participants:
Two hundred eleven healthy toddlers aged 15 to 23 months.
Intervention:
Two injections at 2 months apart of meningococcal C conjugate (group 1, n = 69), plain meningococcal polysaccharide (group 2, n = 72), or hepatitis B virus vaccine (group 3, n = 70). All toddlers received a follow-up dose of plain meningococcal polysaccharide vaccine 12 months later.
Main Outcome Measures:
IgG meningococcal C anticapsular antibody concentrations determined by enzyme-linked immunosorbent assay and complement-mediated bactericidal antibody.
Results:
In group 1, the magnitude of the IgG response to meningococcal C conjugate vaccine was more than 4-fold higher after dose 1 and more than 10-fold higher after dose 2 compared with meningococcal polysaccharide vaccine (group 2) (P<.001). Higher titers persisted in the meningococcal C conjugate group for at least 12 months (P<.001). Group 1, primed with meningococcal C conjugate, had 25-fold higher IgG responses to the meningococcal polysaccharide 1-year booster dose than the controls who had received hepatitis B virus vaccine initially and were given meningococcal polysaccharide vaccine 1 year later for the first time (P<.001). In contrast, group 2, primed with meningococcal polysaccharide, had a 2-fold lower response to the 1-year booster meningococcal polysaccharide dose than the hepatitis B virus control group (P = .006). Serum bactericidal responses paralleled the enzyme-linked immunosorbent assay responses.
Conclusions:
Immunization of toddlers with meningococcal C conjugate vaccine induces high titers of anticapsular and bactericidal antibody. Furthermore, this vaccine induces immunologic memory to meningococcal C polysaccharide. In contrast, meningococcal polysaccharide vaccine is less immunogenic than the conjugate vaccine and also induces a hyporesponsive state that persists for at least 12 months.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
Related Concept Videos
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Vaccines
Poliomyelitis